Dermatomyositis With Rapidly Progressive Interstitial Lung Disease Treated With Rituximab: A Report of 3 Cases in Japan

Internal Medicine - Japan
doi 10.2169/internalmedicine.56.7956
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Rapidly Progressive Interstitial Lung Disease Originating From Clinically Amyopathic Dermatomyositis Associated With Positive Anti-Mda 5 Antibody: A Case Report and Literature Review

SN Comprehensive Clinical Medicine
2019English

Interstitial Lung Disease in Patients With Scleroderma: Treatment With Rituximab

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

Interstitial Lung Disease With Anti-Melanoma Differentiation-Associated Protein 5 Antibody: Rapidly Progressive Perilobular Opacity

Internal Medicine
Internal MedicineMedicine
2019English

Interstitial Lung Disease in Polymyositis and Dermatomyositis

Current Opinion in Rheumatology
Rheumatology
2005English

Antibodies to Endothelial Cells in Dermatomyositis: Association With Interstitial Lung Disease.

BMJ
1991English

Polymyositis-Dermatomyositis and Interstitial Lung Disease in Pregnant Woman Successfully Treated With Cyclosporine and Tapered Steroid Therapy

Case Reports in Rheumatology
2019English

Clinical Features of Polymyositis/Dermatomyositis With Steroid-Resistant Interstitial Lung Disease.

Internal Medicine
Internal MedicineMedicine
1998English

Interstitial Lung Disease Associated With Docetaxel in a Patient Treated for Breast Cancer — A Case Report

Pneumonologia i Alergologia Polska
2015English

A Retired Shipyard Worker With Rapidly Progressive Pulmonary Interstitial Fibrosis

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy